Relationship of plasma beta-carotene and vitamin A to luteal function in postpartum cattle

The influence of plasma concentrations of beta-carotene and vitamin A on in vivo progesterone production by bovine corpora lutea after gonadotropin-releasing hormone-induced LH release was assessed in 39 postpartum dairy cows. Thirty Holsteins and nine Jerseys were given 100 micrograms gonadotropin-releasing hormone on d 12 of an estrous cycle, which began from 30 to 49 d postpartum. Concentrations of beta-carotene and vitamin A in plasma and progesterone and LH in serum were determined prior to gonadotropin-releasing hormone injection (0 h); serum progesterone and LH concentrations were also determined 1, 2, and 3 h after injection of gonadotropin-releasing hormone. Serum concentrations of progesterone and LH were increased by gonadotropin-releasing hormone. Incremental progesterone production in an analysis of covariance was influenced by breed as well as the interactions of breed with vitamin A, of season with beta-carotene, and of season with vitamin A. The regression coefficients were positive for beta-carotene and negative for vitamin A in all cases. In conclusion, luteal function in the postpartum cow appears to be related to plasma concentrations of beta-carotene and vitamin A.     

Fertility of postpartum dairy cows after administration of gonadotropin-releasing hormone and prostaglandin F2 alpha: a field trial

Our objective was to examine further the potential profertility effects of gonadotropin-releasing hormone and prostaglandin F2 alpha in postpartum Holstein cows. Reproductive performance was monitored in 843 cows milked thrice daily. One group of cows (n = 218) was untreated, while three groups received either 100 micrograms gonadotropin-releasing hormone administered once between d 11 and 25 (n = 211); 25 mg prostaglandin F2 alpha given once between d 11 and 25 (n = 215); or 25 mg prostaglandin F2 alpha given once between d 25 and 40 postpartum (n = 190). No profertility effects were detected in cows, regardless of their health status during the periparturient period, except cows given gonadotropin-releasing hormone between d 11 and 18 had shorter intervals to first estrus and to first service than controls. Cows with reproductive disorders (abnormal health status) in the concurrent lactation had longer intervals from calving to conception after receiving gonadotropin-releasing hormone between d 18 and 25 or prostaglandin F2 alpha between d 33 and 40. Abnormal health status adversely affected every reproductive trait measured. Early postpartum treatments with either hormone failed to improve reproductive performance of dairy cows, in contrast to several reports of profertility effects for gonadotropin-releasing hormone, and a few reports for prostaglandin F2 alpha.     

Gonadotropin-releasing hormone and prostaglandin F2 alpha for postpartum dairy cows: estrous, ovulation, and fertility traits

A study of 234 Holstein cows was conducted to determine if early postpartum treatments of gonadotropin-releasing hormone, prostaglandin F2 alpha, or both would alter frequency and occurrence of estrus and ovulation as well as subsequent fertility. Cows in groups 1 and 2 received gonadotropin-releasing hormone (200 micrograms) between 10 and 14 d postpartum, and cows in groups 3 and 4 received saline. Ten days later, cows in groups 2 and 3 received prostaglandin F2 alpha (25 mg), and cows in groups 1 and 4 received saline. Treatment with gonadotropin-releasing hormone reduced intervals to first ovulation and first detected estrus as well as increasing the proportion of cows with three or more ovulations before first service from 57% for saline-treated controls to 83%. Treatment with prostaglandin F2 alpha reduced intervals to second and third ovulation and shortened the first estrous cycle. Treatments for cows in groups 1 and 3 increased the proportion of cows having estrous cycles of normal duration. Interval from calving to conception was reduced by 43 to 48 d for cows with an abnormal puerperium treated with either gonadotropin-releasing hormone or prostaglandin F2 alpha compared with controls (group 4) and by 27 to 29 d overall in all cows in groups 1 and 3. Cows with normal or abnormal puerperium in groups 1 and 3 required 26 to 41% fewer services per conception than controls. We conclude that treatments of gonadotropin releasing hormone or prostaglandin F2 alpha, but not the treatment combination, improved fertility of dairy cows, especially those that experienced puerperal problems.     

Ovarian follicular responses to high doses of pulsatile luteinizing hormone in lactating dairy cattle

Two experiments in lactating dairy cows examined ovarian follicular responses to high, frequent doses of exogenous LH pulses at levels associated with follicular cysts. In Experiment 1, estrus was synchronized in 12 cyclic lactating cows >40 d postpartum. Emergence of the second follicular wave (d 0) was determined by ultrasonography. Starting on d 1, cows received LH (40 microg/h; n = 7) or saline (2 mL/h; n = 5) in hourly pulses for up to 5 (n = 5) or 7 (n = 7) d. On d 2, all cows received two injections of PGF2alpha, 12 h apart. In experiment 2, 14 lactating cows (7 to 12 d postpartum) received LH (40 microg/h; n = 7) or saline (1 mL/h; n = 7) in hourly pulses for 7 d, beginning 24 h after start of the first follicular wave. Daily samples were used to determine serum concentrations of progesterone (P4), estradiol-17beta (E2), LH, and FSH. Profiles of LH were determined from blood samples collected at 12-min intervals for 8 h on d 3. During infusion of LH, serum P4 and FSH were similar across treatments in both experiments. Serum E2 concentrations were similar in experiment 1, but serum E2 was greater on d 2, 3, and 5 in LH-treated cows in experiment 2. Infusion increased LH pulse frequency and amplitude in both experiments. Formation of cysts did not differ between LH- and saline-treated cows in either experiment (1 of 7 vs. 0 of 5 and 1 of 6 vs. 0 of 7, respectively). Cows that ovulated had similar intervals to ovulation in experiment 1 [6.0 +/- 0.1 d (LH) vs. 6.4 +/- 0.2 d (saline)], but in experiment 2, ovulation was 14 d earlier in LH-treated cows (5.6 +/- 1.8 d vs 19.9 +/- 1.5 d). In conclusion, high concentrations of LH are not solely responsible for formation of cysts in lactating dairy cows. Pulsatile infusion of LH stimulated follicular growth and steroidogenesis and decreased time to first ovulation in anestrous postpartum cows.     

Evidence that lamprey GnRH-III does not release FSH selectively in cattle

Experiments were performed to test the hypothesis that lamprey GnRH-III (lGnRH-III) selectively releases FSH. Primary cultures of bovine adenohypophyseal cells were treated with mammalian GnRH (mGnRH) and lGnRH-III (10(-9), 10(-8), 10(-7) and 10(-6) M) or control media in Experiment 1. All doses of mGnRH and the two highest doses of lGnRH-III stimulated (P < 0.001) a non-selective release of LH and FSH. In Experiments 2-4, Latin Square designs were utilized in vivo to examine whether physiological and hormonal milieu regulate putative selective effects of lGnRH-III. In Experiments 2 and 3, ovariectomized cows with basal levels of estradiol only (Experiment 2) or in combination with luteal phase levels of progester-one (Experiment 3) were injected with mGnRH and lGnRH-III (0.055, 0.11, 0.165 and 1.1 microg/kg body weight (BW) and saline. All doses of mGnRH released (P < 0.001) LH and FSH, but only the highest dose of lGnRH-III stimulated (P < 0.001) a non-selective release of both LH and FSH (Experiment 3). For Experiments 4A and 4B, intact, mid-luteal phase cows were injected with mGnRH and lGnRH-III (1.1 microg/kg BW; Experiment 4A), lGnRH-III (1.1 and 4.4 microg/kg BW; Experiment 4B) and saline. As before, mGnRH released (P < 0.001) both LH and FSH at all doses. In contrast, lGnRH-III at the highest dose released (P < 0.001) LH but not FSH. These findings suggest that lGnRH-III may act as a weak competitor for the mGnRH receptor and do not support the hypothesis that it selectively releases FSH in cattle.     

Early postpartum reproductive profiles in Holstein cows with retained placenta and uterine discharges

Sixty Holstein cows were allocated to three groups. Twenty cows had retained placenta. The remaining cows were examined on d 14 postpartum and those with purulent discharges (n = 22) were assigned to one group and the remaining (n = 18) to a control group. Within each group, cows were given randomly either gonadotropin-releasing hormone (i.m., 200 micrograms) or saline on d 15 postpartum to evaluate the effect on changes in ovarian structures and plasma progesterone through 50 d postpartum and fertility. Corpora lutea were found in control cows by d 21, cows with uterine discharge by d 28, and cows with retained placenta by d 27. Maximum progesterone production during the first luteal phase was higher in control cows than in cows with purulent discharge or retained placenta (4.66 ng/ml compared with 3.23 and 3.34 ng/ml, respectively). Duration of the first corpus luteum was affected by clinical condition. Only 6.2% of cows with retained placenta had corpora lutea of normal duration (12 to 16 d), whereas 43.8 and 50.0% of cows with uterine discharge and control cows had normal postpartum luteal phases. Measures of fertility were not affected by gonadotropin-releasing hormone. Control cows had less days to conception (97) and fewer services per conception (1.6) than cows with retained placenta (134 and 2.5, respectively). Clinical group affected reproduction more than gonadotropin-releasing hormone did, possibly by altering ovarian function.     

Changes of luteinizing hormone and progesterone for dairy cows after gonadotropin-releasing hormone at first postpartum breeding

Gonadotropin-releasing hormone administered at breeding enhances fertility of dairy cows, so a study was designed to evaluate the mechanism for enhanced fertility following administration of gonadotropin-releasing hormone at first postpartum breeding. Twenty-four cows were assigned randomly to one of two treatments, 100 micrograms of gonadotropin-releasing hormone intramuscular or saline vehicle intramuscular at insemination. Blood samples for luteinizing hormone assay were taken at 2-h intervals prior to breeding and .5-h intervals for 3 h after insemination. Composite morning milk samples for progesterone assay were collected for 30 days after insemination or until next estrus. Cows given gonadotropin-releasing hormone had higher luteinizing hormone concentrations in blood serum following treatment than cows given saline, 13.2 versus 3.0 ng/ml. There was no relationship between luteinizing hormone and subsequent conception. Progesterone for cows that became pregnant was higher throughout sampling days. Mean progesterone concentrations were 4.6 versus 2.2 ng/ml in pregnant and nonpregnant cows during the first 4 days after insemination. Cows treated with gonadotropin-releasing hormone that conceived had higher progesterone than other cows, and that was evident at the first 4 days postbreeding.     

Influence of gonadotropin-releasing hormone and timing of insemination relative to estrus on pregnancy rates of dairy cattle at first service

The objective was to determine the influence of gonadotropin-releasing hormone on pregnancy rates of dairy cattle at first services, when both the timing of hormone injection and insemination were altered relative to the onset of estrus. Cows (n = 325) were assigned randomly to six groups making up a 2 X 2 X 2 incomplete factorial experiment; dose of GnRH (100 micrograms versus saline), timing [1 h (early) or 12 to 16 h (late) after first detected estrus] of AI, and timing of hormone injection (early versus late) were the three main effects. Cows were observed for estrus 4 times daily. Treatments and resulting pregnancy rates were: 1) hormone injection early plus AI early (35%), 2) hormone injection late plus AI early (34%), 3) saline injection early plus AI early (30%), 4) hormone injection late plus AI late (30%), 5) hormone injection early plus AI late (46%), and 6) saline injection late plus AI late (43%). Pregnancy rate in the first four groups (32%) was less than that in the latter two groups (44%). Concentrations of LH in serum were greater for cows given hormone or saline injections in early estrus than for cows injected with either hormone of saline during late estrus. Concentrations of LH in serum 2 h after GnRH were elevated above those of controls, whether GnRH was injected during early or late estrus. Neither concentrations of LH during estrus nor concentrations of progesterone 8 to 14 d after estrus explained the possible antifertility effect of GnRH given during late estrus.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effects of gonadotropin-releasing hormone and human chorionic gonadotropin on pregnancy rate in dairy cattle

This study was to determine if gonadotropin-releasing hormone, human chorionic gonadotropin, or their interaction would affect pregnancy rate or milk progesterone profiles in dairy cattle. Cows and heifers eligible for first, second, and third services were assigned to four treatments: 1) saline i.m. within 5 min after AI (d 0) and saline 15 d after AI (n = 222 AI); 2) gonadotropin-releasing hormone (100 micrograms) i.m. within 5 min after AI and saline on d 15 (n = 223); 3) saline after AI and human chorionic gonadotropin (3500 IU) i.m. on d 15 (n = 196); 4) gonadotropin-releasing hormone at AI and human chorionic gonadotropin on d 15 (n = 195). Progesterone was quantified in milk samples collected twice weekly for 5 wk from all cows. Neither gonadotropin-releasing hormone, human chorionic gonadotropin, gonadotropin-releasing hormone x human chorionic gonadotropin interaction, age, nor service number affected pregnancy rate, which averaged 46.2%. Pregnancy and human chorionic gonadotropin affected milk progesterone profiles. Pregnancy maintained progesterone concentrations and human chorionic gonadotropin on d 15 increased them. This study does not support the general use of gonadotropin-releasing hormone at AI or human chorionic gonadotropin 15 d after AI as methods for enhancing pregnancy rates of dairy cattle.     

Gonadotropin requirements for dominant follicle selection in GnRH agonist-treated cows

A study was conducted to examine the effects of gonadotropins on ovarian follicular development and differentiation in GnRH agonist (GnRHa)-treated cattle. Holstein cows were allotted into two pre-treatment groups: controls (n = 5) and GnRHa-treated (n = 9). Ovaries were removed from control cows on day 5 following a synchronized estrus. Treatment with GnRHa resulted in follicular arrest at <5 mm. Following follicular arrest, GnRHa-treated cows received a constant infusion of FSH for 96 h (GnRHa/FSH), with a randomly selected subset receiving hourly pulses of LH in addition to FSH during the last 48 h of infusion (GnRHa/FSH + LH). At the end of infusion, ovaries were removed, follicles were counted and measured, and follicular fluid samples were collected from large follicles (>10 mm). Differences in expression of mRNA for LH receptor, FSH receptor, cytochrome P450 side-chain cleavage, 3beta-hydroxysteroid dehydrogenase, cytochrome P450 17alpha-hydroxylase (P450c17) and cytochrome P450 aromatase were determined in large follicles using in situ hybridization. The number of large follicles did not differ between GnRHa/FSH-treated and GnRHa/FSH + LH-treated cows (P = 0.64), but was greater than control animals (P < or = 0.004). Follicular fluid concentrations of estradiol-17beta and androstenedione were highest in GnRHa/FSH + LH-treated cows (P < or = 0.04), intermediate in control cows, and lowest in GnRHa/FSH-treated cows. Hybridization intensity of P450c17 was greater in GnRHa/FSH + LH-treated versus control or GnRHa/FSH-treated cows (P < or = 0.03). These results indicate that while FSH can support bovine follicular growth >10 mm, LH increases androgen production and expression of P450c17.     

First postpartum luteal function in dairy cows after ovulation induced by progestogen and gonadotropin-releasing hormone

The objective was to determine the effects of progestogen treatment on the lifespan of the first corpus luteum induced by GnRH in periparturient-milked cows. Dairy cows (n = 55) were assigned randomly following normal parturitions to receive either a progestogen implant (6 mg of norgestomet) or a blank implant (control) for 6 d beginning 2 to 5 d after calving. Fifty micrograms of GnRH were administered i.m. 72 h after implant removal to induce ovulation. Concentrations of LH and FSH in serum from 24 to 30 h and from 66 to 72 h after implant removal were similar among treatments. The magnitude of LH released after GnRH injection was higher in progestogen-treated cows (7.6 +/- .9 ng/ml) than in controls (5.3 +/- .9 ng/ml). Concentrations of estradiol in serum from the beginning of the implant period until 3 d after GnRH injection were higher in cows receiving progestogen (9.1 +/- 1.7 pg/ml) than in controls (5.6 +/- 1.7 pg/ml). The proportion of cows that responded to GnRH (elevated concentrations of progesterone in serum greater than .5 ng/ml within 3 to 5 d after injection) tended to be higher in cows receiving progestogen (24 of 28) than in control cows (19 of 27). By definition, interval to first ovulation after GnRH injection was shorter in cows responding to GnRH (3.8 +/- .5 d) than in those failing to respond (20.2 +/- .9 d).(ABSTRACT TRUNCATED AT 250 WORDS)     

Reproductive performance of dairy cows with cystic ovaries following administration of Procystin

Eighty-five postpartum Holstein cows were randomly assigned to receive 0, 50, 100, or 250 micrograms of the gonadotropin-releasing hormone product, Procystin when follicular cysts were diagnosed by palpation per rectum. Accurate reproductive records were maintained, and milk samples were collected at the time of diagnoses for assay for progesterone. An additional 101 cows were injected with only the 100 micrograms dose of Procystin when cysts were identified. Data showed that days from treatment to first observed estrus decreased with increasing doses of Procystin with no advantage of 250 micrograms over 100 micrograms. Days open and conception rates were similar among the treatment groups. Cows with less than 1 ng/ml progesterone in their milk at the time of treatment returned to estrus sooner than cows with progesterone concentrations greater than 1 ng/ml. In addition, gonadotropin-releasing hormone administered to those cows with low progesterone at the time of treatment led to significantly increased progesterone concentrations by 7 and 14 d posttreatment. We conclude that although Procystin administration hastened estrus of cows with ovarian cysts, breeding practices on the farms did not lead to an improvement in reproductive efficiency of the cows that possessed cysts.     

Effect of dietary protein and exogenous gonadotropin-releasing hormone on circulating progesterone concentrations and performance of Holstein cows

Sixty-three Holstein cows were used in a 2 x 2 factorial arrangement of treatments to determine the effects of dietary protein and exogenous gonadotropin-releasing hormone on performance postpartum and on circulating concentrations of progesterone. The experimental diets, 14 or 20% CP (dry basis), were fed from parturition to 14 wk postpartum. Blood serum urea N was elevated in the cows fed the 20% versus 14% CP diet. Feed intake was increased, but yield and composition of milk were not affected by the higher protein diet. Circulating concentrations of progesterone were lower in cows fed 20% than 14% protein on d 12 of both the synchronized and subsequent estrous cycles. Exogenous gonadotropin-releasing hormone administered on d 12 of the preceding estrous cycle did not increase the concentration of progesterone on d 12 of the subsequent estrous cycle. Luteal phase concentrations of progesterone were reduced by high dietary protein, but were not affected by gonadotropin-releasing hormone given on d 12 of the preceding cycle.     

Gonadotropin-releasing hormone and conception of Holsteins

Effects of gonadotropin-releasing hormone (100 micrograms) and time of artificial insemination on fertility, were examined in lactating dairy cows at first, second, and third services. Inseminations were either soon after detected estrus (0 h) or 12 h later, and cows were given gonadotropin-releasing hormone or saline after inseminations. Conception at first service was not improved by hormone treatment. But conception rates at repeat services were improved by nearly 21% when cows were treated with gonadotropin-releasing hormone within 30 s after insemination. Inseminations soon after detection of estrus (0 h) followed by hormone treatment resulted in the highest conception rates for all services. Time of the insemination (0 versus 12 h) had no effect on conception. Administering gonadotropin-releasing hormone at repeat services should improve conception rate of lactating dairy cows.     

Effects of the persistent dominant follicle on the ability of follicle stimulating hormone to induce follicle development and ovulatory responses

Three experiments were conducted to evaluate the effect of an induced first wave persistent dominant follicle on folliculogenesis and ovulatory responses induced by FSH. On d 6 of a synchronized estrous cycle (d 0 = estrus), cows were treated with a Syncromate-B implant and two injections of PGF2, (25 mg, 0700 h; 15 mg, 1900 h, i.m.). Cows in the control group retained a first-wave persistent dominant follicle, but in the aspirated group, the first-wave dominant follicle was removed via transvaginal aspiration on d 10 (d 0 = estrus). Beginning on d 12, cows received 32 mg of FSH-P i.m. in decreasing doses at 12-h intervals over a 4-d period. On d 15, the Syncromate-B implant was removed, and cows were ovariectomized (experiment 1, n = 8) or inseminated (experiment 2, n = 11) at 10 and 22 h after the onset of estrus. Cows in experiment 3 received a used controlled intravaginal drug releasing (CIDR) device and two injections of PGF2alpha (25 mg, 0700 h; 15 mg, 1900 h; i.m.) on d 6. On d 8, the first-wave dominant follicle was aspirated (n = 6) or left intact (n = 5), and FSH treatment was initiated (20 mg of Folltropin in decreasing doses at 12-h intervals over a 4-d period), and on d 10 the used CIDR device was removed from all cows. Ovarian follicle size and number were examined daily by ultrasonography from d 5 of the estrous cycle. The persistent dominant follicle increased in size from 10.7 mm on d 5 to 15.4 mm on d 10 (experiments 1 and 2), and from 9 mm on d 5 to 20.4 mm on d 11 (experiment 3). From d 11 to 14, the number of class 1 (2 to 5 mm) follicles was lower in the aspirated group than in the control group; the number of class 2 (6 to 9 mm) follicles was higher on d 12 and 13 for the aspirated group (experiments 1 and 2). The number of class 3 (> or =10 mm) follicles was higher in the aspirated group on d 14 to 16, but the same on d 17. Ovarian and embryo responses to superovulation did not differ between groups. In experiment 3, the numbers of class 1, 2, and 3 follicles, as well as ovarian and embryo responses following ovulation did not differ between groups. Initiation of exogenous FSH treatment appears to override any systemic inhibitory effect that a persistent dominant follicle may be exerting at the pituitary and possibly the ovary.     

Energy balance, metabolic status, and the first postpartum ovarian follicle wave in cows administered propylene glycol

Mature Holstein cows were drenched daily with either 500 mL of water (control; n = 28) or propylene glycol (PPG; n = 28) from d 10 before parturition until d 25 postpartum. Follicular development was monitored thrice weekly by transrectal ultrasound. Blood samples were collected every 30 min from a subset of 10 cows per treatment on d −10, 2, and 25 to assess glucose and insulin response to treatments, and on d 10 postpartum, blood was collected every 10 min for 12 h to determine LH pulse profiles. Both insulin and glucose were elevated on d 2 and 25 following PPG administration, but only insulin was elevated on d −10. On d 10 postpartum, the number of LH pulses, mean LH, and pulse amplitude were not different between control and PPG cows. The proportion of first postpartum dominant follicles that became ovulatory, atretic, or cystic was not different between control and PPG cows. Despite evidence of improved metabolic status, PPG failed to increase LH pulse frequency, and failed to increase the proportion of first postpartum follicle waves resulting in ovulation. The dominant follicle of each cow was retrospectively categorized as being ovulatory (n = 17), nonovulatory high estradiol (n = 6), nonovulatory low estradiol (n = 24), or cystic (n = 8). Differences in dry matter intake and energy balance among cows in the different follicle categories were apparent as early as 3 wk before parturition. The nonovulatory low estradiol cows had lower pre- and postpartum dry matter intake and energy balance compared with ovulatory cows. The nonovulatory low estradiol cows also had postpartum metabolic hormone and metabolite profiles indicative of more severe negative energy balance.     

Potential treatment of fatty liver with 14-day subcutaneous injections of glucagon

Fatty liver is a major metabolic disease of dairy cows in early lactation that can be treated with 14-d continuous, intravenous infusions of 10 mg/d of glucagon. The objective was to test whether similar effects can be obtained with 14-d subcutaneous 7.5- or 15-mg daily dosages of glucagon beginning at d 8 postpartum. Multiparous Holstein cows (n = 32) were grouped on the basis of their liver triacylglycerol concentration at d 8 postpartum into "normal" (n = 8; triacylglycerol < 1% liver wet wt) and "susceptible" (n = 24; triacylglycerol > 1% liver wet wt) cows. Susceptible cows were assigned randomly to three groups and beginning at d 8 postpartum received 0, 2.5, or 5 mg of glucagon in 60 ml of saline by subcutaneous injections every 8 h for 14 d. Beginning at d 8 postpartum, normal cows received 60 ml of saline by subcutaneous injections every 8 h for 14 d. Both dosages of glucagon increased concentrations of plasma glucose and insulin and decreased concentrations of plasma nonesterfied fatty acids. Glucagon injections of 15 mg/d decreased concentrations of liver triacylglycerol in cows older than 3.5 yr, but not in younger multiparous cows. Our results document that subcutaneous injections of glucagon have the potential to decrease the degree of fatty liver in older dairy cows in early lactation.     

Effect of high crude protein on pituitary and ovarian function in Holstein cows

Intact and ovariectomized cows were used to determine the effect of high amounts of dietary crude protein on pituitary regulation of luteinizing hormone. Estrus was synchronized with prostaglandin F2 alpha in 10 intact dry cows fed 15 or 25% crude protein, and serum luteinizing hormone profiles were evaluated during both follicular and luteal phases of the estrous cycle. Serum progesterone, pituitary luteinizing hormone content, and luteinizing hormone-releasing hormone receptors were also measured. Basal concentrations of serum luteinizing hormone tended to be lower during the follicular phase and were significantly higher during the luteal phase in cows fed 25% crude protein. Serum progesterone was not affected by dietary treatment. In 10 ovariectomized cows fed 24% crude protein, amplitude of luteinizing hormone response to luteinizing hormone-releasing hormone challenge tended to be smaller than that of 8 cows fed 16% crude protein, although total luteinizing hormone released in response to luteinizing hormone releasing hormone challenge was not different between dietary treatments. In both intact and ovariectomized cows, pulsatile luteinizing hormone patterns, pituitary luteinizing hormone content, and luteinizing hormone-releasing hormone receptors were not influenced by treatment. High dietary crude protein did not have a primary effect on luteinizing hormone or progesterone in nonlactating cows.     

Supplemental nicotinic acid or nicotinamide for lactating dairy cows

In two experiments with multiparous Holstein cows, the effects of feeding supplemental nicotinic acid or nicotinamide on milk production and metabolite changes associated with early lactation were measured. In Experiment 1, 30 cows were assigned to three groups. The treatment groups received 6 g nicotinic acid or 6 g nicotinamide per head per day beginning 2 wk prepartum to 12 wk postpartum. Control group received no treatment. Cows receiving nicotinamide produced more milk (wk 9, 11, and 12) and had higher milk fat test (wk 1 and 4) than did controls. Concentrations of beta-hydroxybutyrate in blood serum (wk 4) were lower for cows receiving nicotinic acid or nicotinamide. Serum glucose concentration (wk 4 to 6) was higher and FFA (wk 4) were lower for cows receiving nicotinamide than for controls. In Experiment 2 with six multiparous Holstein cows, the effects of feeding nicotinamide on metabolic changes associated before, during, and after a 48-h period without feed initiated at 4 wk postpartum were studied. The treatment groups received 12 g nicotinamide per head per day beginning 2 wk prepartum to 4 wk postpartum. The control group received no treatment. Supplementing nicotinamide to lactating cows had no effect on serum glucose, beta-hydroxybutyrate, or free fatty acids before, during, or after 48-h period without feed.     

Extending the postpartum anovulatory period in dairy cattle with estradiol cypionate

Estradiol cypionate (ECP), a long-acting estrogen, has been used therapeutically in early postpartum (PP) dairy cows. In experiment 1, effects of ECP on circulating reproductive hormones, cyclicity, and ovarian function in early PP dairy cows were investigated. Lactating Holsteins received 10 mg of ECP (ECP; n = 17) or placebo (CON; n = 16) on d 7 PP. Serum and ultrasound data were acquired from 5 to 90 d of lactation. Compared to CON, ECP cows had greater serum estradiol for 10 d and lower serum FSH for 15 d posttreatment. After ECP, the appearance of follicles > or = 10 mm and time to first ovulation were delayed. Nevertheless, by 90 d PP, normal estrous cycles were found in only 50% of CON versus 88% of ECP cows. Primiparous, but not multiparous, cows receiving ECP had higher milk yields. Experiment 2 investigated effects of ECP on reproduction and milk production on a commercial dairy. Cows were blocked by parity and randomized to three treatments: 0 (n = 85), 4 (n = 85), or 10 (n = 86) mg of ECP on d 5 to 8 PP. Data included cycling status (two ultrasound examinations at 30 to 33 d PP and 7 d later), individual reproduction records, and daily milk yields from 10 to 90 d PP. In primiparous cows, ECP had no significant effects on ovulatory status or milk yields. By 40 d PP, a greater percentage of multiparous cows receiving 10 mg of ECP remained anovulatory compared with those receiving 0 or 4 mg. Milk yields were highest for multiparous cows receiving 4 mg of ECP, intermediate for the 10-mg dose, and lowest for controls. Lower conception was observed in multiparous cows receiving 4 mg of ECP. In summary, ECP delayed time to first ovulation particularly in multiparous cows, an effect associated with observed inhibition of circulating FSH. Milk yield responses to ECP were inconsistent within parity groups across the two experiments.